Significance of plasma cell syncytium in multiple myeloma.

被引：0
|
作者：
Mullai, N [1 ]
Samuel, J [1 ]
Agbemadzo, B [1 ]
Dissanayake, R [1 ]
Yadav, S [1 ]
机构：
[1] Cook Cty Hosp, Dept Med Oncol & Hematol, Chicago, IL 60612 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4958
引用
收藏
页码：302B / 302B
页数：1
相关论文
共 50 条
  • [21] Prognostic significance of BCL-2 expression in patients with multiple myeloma.
    Hashmi, M
    Kojouri, K
    Yang, J
    Patel, S
    Khan, M
    Sylvester-Kohrt, N
    Kamble, R
    Selby, GB
    Ozer, H
    Kharfan-Dabaja, MA
    BLOOD, 2004, 104 (11) : 292B - 293B
  • [22] CD200 Expression in Plasma Cell Myeloma.
    Olteanu, H.
    Harrington, A. M.
    Kroft, S. H.
    MODERN PATHOLOGY, 2011, 24 : 312A - 313A
  • [23] Dendritic cell based idiotype vaccination in multiple myeloma.
    Bohlen, H
    Titzer, S
    Christensen, O
    Manzke, O
    Wolf, J
    Thiele, J
    Diehl, V
    Tesch, H
    BLOOD, 1997, 90 (10) : 2577 - 2577
  • [24] Prevalence and significance of clonal hematopoiesis of indeterminate prognosis (CHIP) in multiple myeloma.
    Padrnos, Leslie Jane
    LaPlant, Betsy
    Kumar, Shaji
    Henderson, Kimbery
    Dispenzieri, Angela
    Lasho, Terra L.
    Patnaik, Mrinal
    Stewart, A. Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Plasma concentration of thalidomide and clinical efficacy in patients with multiple myeloma.
    Hattori, Y
    Kakimoto, T
    Okamoto, S
    Iguchi, T
    Morita, K
    Tanigawara, Y
    Ikeda, Y
    BLOOD, 2003, 102 (11) : 689A - 689A
  • [26] Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology
    Goasguen, JE
    Zandecki, M
    Mathiot, C
    Scheiff, JM
    Bizet, M
    Ly-Sunnaram, B
    Grosbois, B
    Monconduit, M
    Michaux, JL
    Facon, T
    LEUKEMIA RESEARCH, 1999, 23 (12) : 1133 - 1140
  • [27] Correlation of serum free light chains and bone marrow plasma cell infiltration in multiple myeloma.
    Mead, GP
    Reid, SD
    Augustson, BM
    Drayson, MT
    Bradwell, AR
    Child, JA
    BLOOD, 2004, 104 (11) : 299B - 299B
  • [28] Gene expression profiling of plasma cell dyscrasias: The role of IGH translocations in the heterogeneity of multiple myeloma.
    Neri, A
    Mattioli, M
    Agnelli, L
    Fabris, S
    Baldini, L
    Morabito, F
    Bicciato, S
    Verdelli, D
    Intini, D
    Nobili, L
    Cro, L
    Pruneri, G
    Callea, V
    Stelitano, C
    Lombardi, L
    BLOOD, 2004, 104 (11) : 294B - 294B
  • [29] Molecular cytogenetic study of immunofluorescently labeled plasma cells and prognostic significance of clonal chromosomal aberrations in multiple myeloma.
    Michalova, Kyra
    Zemanova, Zuzana
    Pavlistova, Lenka
    Tajtlova, Jana
    Spicka, Ivan
    Zounar, Rene
    Gregora, Evzen
    Smolikova, Alena
    Chrz, Michal
    Obernauerova, Jarmila
    Walterova, Lenka
    BLOOD, 2006, 108 (11) : 341B - 341B
  • [30] Differential expression of telomerase activity in plasma cells from patients with monoclonal gammopathy of undetermined significance and multiple myeloma.
    Cheryk, LA
    Katzmann, JA
    Ahmann, GJ
    Greipp, PR
    O'Kane, DJ
    CLINICAL CHEMISTRY, 1999, 45 (06) : A108 - A108
12345